𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11

✍ Scribed by Shamiram Feinglass; Atul Deodhar

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
88 KB
Volume
44
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of YM294, recombinant human inter
Effect of YM294, recombinant human interleukin-11, on carboplatin-induced thrombocytopenia in rats
✍ Katsunari Taguchi; Masaharu Asano πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 478 KB

We investigated the effects of YM294, recombinant human interleukin-11, on changes in blood cell levels in carboplatin-treated rats. Continuous infusion of YM294 was carried out by either intravenous or subcutaneous injection (10 and 100 micrograms/rat/day) for 14 days via an implanted osmotic pump.

Pharmacoeconomic analysis of oprelvekin
Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy
✍ Scott B. Cantor; Linda S. Elting; David V. Hudson Jr.; Edward B Rubenstein πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 315 KB

## Abstract ## BACKGROUND Previous research has shown oprelvekin (recombinant human interleukin‐11 [rhIL‐11]) to be effective in reducing the requirements for platelet transfusions after myelosuppressive chemotherapy in patients who have previously experienced thrombocytopenia. The economic conseq